TOKAI PHARMACEUTICALS INC's ticker is TKAI and the CUSIP is 88907J107. A total of 54 filers reported holding TOKAI PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $13,000 | -78.7% | 15,755 | -74.7% | 0.00% | – |
Q4 2016 | $61,000 | +84.8% | 62,327 | +192.1% | 0.00% | – |
Q3 2016 | $33,000 | -76.9% | 21,337 | -17.8% | 0.00% | – |
Q2 2016 | $143,000 | +31.2% | 25,968 | +33.3% | 0.00% | – |
Q1 2016 | $109,000 | -25.3% | 19,486 | +16.7% | 0.00% | – |
Q4 2015 | $146,000 | +14.1% | 16,702 | +35.0% | 0.00% | – |
Q3 2015 | $128,000 | -21.0% | 12,368 | +1.4% | 0.00% | – |
Q2 2015 | $162,000 | -4.1% | 12,193 | -18.4% | 0.00% | – |
Q1 2015 | $169,000 | -68.1% | 14,935 | -58.4% | 0.00% | – |
Q4 2014 | $530,000 | – | 35,935 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Green Owl Capital Management, LLC | 132,500 | $1,155,000 | 1.36% |
Novo Holdings A/S | 470,946 | $4,107,000 | 0.40% |
Opus Point Partners Management, LLC | 62,007 | $541,000 | 0.36% |
Perceptive Advisors | 485,338 | $4,232,000 | 0.31% |
NJ State Employees Deferred Compensation Plan | 35,000 | $305,000 | 0.06% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 87,983 | $767,000 | 0.04% |
ROPES WEALTH ADVISORS LLC | 6,000 | $52,000 | 0.02% |
Alyeska Investment Group, L.P. | 251,797 | $2,196,000 | 0.02% |
A.R.T. Advisors, LLC | 27,490 | $239,000 | 0.01% |
ALPS ADVISORS INC | 29,753 | $259,000 | 0.00% |